Øjenforskning OUH

Fighting to eradicate visual loss and provide world-class treatment for patients with eye diseases!

[Benjamin Thinggaard @Bthinggaard16]

Great news for wet AMD patients receiving anti-VEGF injections! Our recently published study reveals no increased mortality risk. Previous studies had prompted questions on this matter. @AAOjournal @OUH_Eye @OUHhospital @SyddanskUni @ARVOinfo https://t.co/5ooyEJgZeL

[Øjenforskning OUH @OUH_Eye]

Nyeste artikel fra forskningsenheden forfattet af @LowaterSimon @JakobGrauslund @YousifSubhi
og @AnnaVergmann der giver et overblik over nuværende viden omkring port delivery ranibizumab 💉

[Ophthalmology Ther @Ophthal_Therapy]

Clinical Trials and Future Outlooks of the Port Delivery System with Ranibizumab: A Narrative Review - https://t.co/fmm7EjG0mN #Ophthalmology

[Øjenforskning OUH @OUH_Eye]

An incredibly important study, originating from @OUH_eye, emphasizing the challenges we face in the treatment of wet AMD. 📚💡 #AMD #Research #EyeHealth @VELUXFONDEN @SyddanskUni @P4Fyn @tv2fyn @YoungRetina @JAMANetworkOpen

[JAMA Network Open @JAMANetworkOpen]

Intravitreal VEGF inhibitor injections in Danish patients has grown considerably, with >900k injections given to 56k patients (13.8 per 1000 citizens), 2007-2022, and an anticipated 50% increase by 2027. Age & conditions play a role. https://t.co/JTjkRW0jgn

[Øjenforskning OUH @OUH_Eye]

Proud to announce that @AnnaVergmann, MD, PhD, has joined us new Associate Professor in #Ophthalmology . Anna will be spearheading our research in ocular simulation in educational skills and surgery and make us rise towards the stars. @OUHhospital @SUND_SDU

[Frederik N Pedersen @FrederikNP]

What a milestone on my academic journey! It’s been incredible diving into the intersection of diabetic retinopathy and mental health 🧠👁 Gratitude to all who help me through this PhD journey🙏🏻

[Øjenforskning OUH @OUH_Eye]

👁️Online now: our newest publication!👁️
Highlighting that bariatric surgery is not associated with short- or long-term worsening of diabetic retinopathy in patients with type 2 diabetes https://t.co/Iab6EUxDtW

[Øjenforskning OUH @OUH_Eye]

@YoungRetina @Retina_Int @OUH_Eye @VELUXFONDEN @DRNyheder @tv2nyhederne @LonnyStokholm @ODIN_OUH @OUHhospital @Ugeskriftet @dagensmedicin @CaspaseMC @DDEA_Denmark @SDCOdense @koebenhavns_uni #scicomm #research #science #diabetes

[Øjenforskning OUH @OUH_Eye]

Just published our research on the link between diabetic eye disease and severe lung disease. Our findings reveal a significantly elevated risk of lung disease among individuals with diabetes. Grateful for the invaluable contributions of our collaborators.

[Heliyon @HeliyonJournal]

Online now: #Diabetic #retinopathy is a predictor of chronic #respiratory failure: A nationwide register-based cohort study https://t.co/3wzdOt5RDq

@Bthinggaard16 @JakobGrauslund @Annethykjaer @LonnyStokholm

Read more like this at: #HeliyonClinical

[Øjenforskning OUH @OUH_Eye]

Join us for a delightful Brunsviger! (a beloved Funen tradition). Two more papers accepted last week, making it a total of 20 accepted in 2023 (speed: 1/8 days). Let's keep up the pace after enjoying some cake!

[Øjenforskning OUH @OUH_Eye]

Wonderful #EAsDEC23 meeting in beautiful Coimbra 🇵🇹 So much new, exciting research 📰 We represented our team by presenting results in both paper- and poster sessions 👁️

[Øjenforskning OUH @OUH_Eye]

Nice to have a chat with many impassioned students at Fang-en-forsker at @SUND_SDU @SyddanskUni 😎 What a bright future for ophthalmologic research!

[Øjenforskning OUH @OUH_Eye]

Ready to woo new talents for the Research unit of Ophthalmology at Fang-en-forsker 🕶️ @SUND_SDU @SyddanskUni

[Benjamin Thinggaard @Bthinggaard16]

Yesterday, I had the great honor to present my study about decreased risk of all-cause mortality among patients with wet AMD at ARVO 2023, New Orleans. What a huge stage, what a big audience and what a great pleasure. Thanks to #ARVO2023 for giving me the opportunity. #speaker

[Øjenforskning OUH @OUH_Eye]

Still a high one-year risk of progression to PDR for patients with severe NPDR (ICDR-level 3)? The quick answer is NO!

Read more in this nation-wide study of 201,945 patients with diabetes just published by Dinesen et al.

https://t.co/W4TqS9U572

@OUHhospital @SUND_SDU

[Øjenforskning OUH @OUH_Eye]

Out latest publication fresh of the press today! We examined inter grader reliability in the Danish screening program for diabetic retinopathy - and spoiler alert; the Danish ophthalmologists are excellent at grading DR 👁️ #actaophtalmologica https://t.co/XVH5TOTPTA

[Øjenforskning OUH @OUH_Eye]

Population-based data on safety of vascular endothelial growth factor inhibitory treatment in retinal vein occlusion by @KatrineHartFred and colleagues is now available open access. Check it out at https://t.co/C0DLJCHfrK.
@YoungRetina @AAOjournal #rvo #vegfinhibitors

[Øjenforskning OUH @OUH_Eye]

Want an insight into the results of adding navigated retinal laser in the treatment of macular edema due to branch retinal vein occlusion? Check out this open access article https://t.co/Sonk6MtCzE by @KatrineHartFred and colleagues in @ActaOphthalmol

[Øjenforskning OUH @OUH_Eye]

@FrederikNP is DONE with ARVO 2023 abstract submission!
Hot Topic again this year, third time in a row?🤞🏻
@YousifSubhi are you joining as our plus-one?

[Yousif Subhi @YousifSubhi]

Regeringsgrundlaget side 42:
"Regeringen vil derudover arbejde for, at der etableres speciallægepraksisser i de dele af landet, hvor de ikke er til stede i dag."
Vi har ledige øjenlæger i Danmark, vi er klar #dkpol
https://t.co/xyUNkG3YYR

[Jakob Grauslund @JakobGrauslund]

Brilliant PhD defence by @KatrineHartFred. Congratulations with this marvelous achievement 👏💐🎉🎁